ELASMOGEN
Live / Registered — Registered (as of 19 Nov 2024)
What this means for you
Registered since 19 Nov 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79379490
- Registration number
- 7567642
- Mark type
- Stylized text
- Filed
- 19 Apr 2023
- Published for opposition
- 03 Sept 2024
- Registered
- 19 Nov 2024
- Attorney of record
- Charlene M. Krogh
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for treatment of cancer, inflammatory diseases, auto-inflammatory diseases, autoimmune diseases and eye diseases and disorders; biological preparations for treatment of cancer, inflammatory diseases, auto-inflammatory diseases, autoimmune diseases and eye diseases and disorders; diagnostic preparations agents, and substances for medical purposes; anti-angiogenesis preparations; anti-cancer preparations; anti-inflammatory preparations; pharmaceutical and biochemical preparations for the treatment or prevention of cancer, infectious disease, physiological disorders, hormonal disorders, inherited disease, single gene disorders, respiratory diseases, gastro-intestinal disorders, circulatory disorders, dermatological conditions, immuno-deficiencies, organ damage, cell proliferation, peripheral neurological disorders, genitourinary disorders, musculoskeletal disorders, and blood disorders; diagnostic reagents for medical use; DNA, antibodies and proteins for medical diagnosis purposes; DNA and antibodies and proteins that stimulate cells for medical use; DNA, antibodies and proteins for therapeutic use for treatment of cancer, inflammatory diseases, auto-inflammatory diseases, autoimmune diseases and eye diseases and disorders; diagnostic preparations for medical purposes; reagents for medical use
- Class 042 — Scientific and technological services: Medical and pharmacological research services; scientific and technological services, namely scientific research, analysis and testing in the field of cancer, inflammatory diseases, auto-inflammatory diseases, autoimmune diseases, eye diseases and disorders, and intracellular delivery of pharmaceuticals and therapeutics; scientific research for medical purposes in the field of cancer, inflammatory diseases, auto-inflammatory diseases, autoimmune diseases, eye diseases and disorders, and intracellular delivery of pharmaceuticals and therapeutics; pharmaceutical research and drug development services; pharmaceutical testing; research and development in the biotechnology field; research and development services in the field of antibodies; biotechnology research services; scientific research in the nature of conducting clinical trials for others; biological research, clinical research and medical research; providing scientific information about the results of clinical trials for pharmaceutical products; research services in the field of diagnostic preparations; scientific laboratory services; custom design and development of biochemical assays; scientific and medical research laboratory services; research and development of new products for others; scientific research and analysis in the field of drug discovery; new product development in the field of pharmaceuticals for others; scientific advisory services, namely, medical advisory services related to pharmaceutical development and testing; scientific research consultancy in the field of cancer research, inflammatory disease research, auto-inflammatory disease research, autoimmune disease research, eye disease and disorder research, and intracellular delivery research of pharmaceuticals and therapeutics; scientific research and development; scientific research in the field of biotechnology and pharmaceuticals; consulting services for others in the field of design, planning, and implementation and project management of scientific research and clinical trials; providing scientific research information; technical advisory services relating to scientific and clinical research; provision of technical and scientific information and consultancy in relation to the aforesaid services.
- Class 044 — Medical, beauty and agricultural services: Medical services; medical advisory services relating to the treatment, relief and prevention of cancer, infectious disease, physiological disorders, hormonal disorders, inherited disease, single gene disorders, respiratory diseases, gastro-intestinal disorders, circulatory disorders, dermatological conditions, immuno-deficiencies, organ damage, cell proliferation, peripheral neurological disorders, genitourinary disorders, musculoskeletal disorders, and blood disorders; preparation and provision of medical reports to patients and medical professionals; preparation and provision of medical information in the form of reports on pharmaceuticals, advanced therapy medicinal products, and therapeutic antibodies to patients and medical professionals; consultancy, advice and information in the field of healthcare, pharmaceuticals and advanced therapy medicinal products
Owner
- Elasmogen Ltd, GB
- Elasmogen Ltd, GB
- Elasmogen Ltd, GB
Prosecution history
- 03 May 2025 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 16 Apr 2025 — FINAL DISPOSITION NOTICE SENT TO IB
- 16 Apr 2025 — FINAL DISPOSITION PROCESSED
- 14 Mar 2025 — NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
- 27 Feb 2025 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 27 Feb 2025 — NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
- 19 Feb 2025 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 19 Nov 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 19 Nov 2024 — REGISTERED-PRINCIPAL REGISTER
- 03 Sept 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 03 Sept 2024 — PUBLISHED FOR OPPOSITION
- 14 Aug 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 31 Jul 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 29 Jul 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 29 Jul 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE